tiprankstipranks
Trending News
More News >
Kobayashi Pharmaceutical Co (JP:4967)
:4967
Japanese Market

Kobayashi Pharmaceutical Co (4967) Financial Statements

Compare
0 Followers

Kobayashi Pharmaceutical Co Financial Overview

Kobayashi Pharmaceutical Co's market cap is currently ¥397.37B. The company's EPS TTM is ¥63.52; its P/E ratio is 39.57; and it has a dividend yield of 1.78%. Kobayashi Pharmaceutical Co is scheduled to report earnings on February 10, 2025, and the estimated EPS forecast is ¥50.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 165.60B¥ 173.46B¥ 166.26B¥ 155.25B¥ 150.51B
Gross Profit¥ 87.60B¥ 96.38B¥ 92.33B¥ 88.77B¥ 85.27B
Operating Income¥ 24.86B¥ 25.78B¥ 26.67B¥ 26.07B¥ 25.94B
EBITDA¥ 32.73B¥ 33.65B¥ 31.86B¥ 30.79B¥ 29.91B
Net Income¥ 10.07B¥ 20.34B¥ 20.02B¥ 19.71B¥ 19.20B
Balance Sheet
Cash & Short-Term Investments¥ 65.75B¥ 79.84B¥ 104.53B¥ 109.05B¥ 94.34B
Total Assets¥ 265.37B¥ 267.47B¥ 255.83B¥ 252.55B¥ 238.37B
Total Debt¥ 846.00M¥ 987.00M¥ 792.00M¥ 630.00M¥ 688.00M
Net Debt¥ -50.03B¥ -70.55B¥ -95.44B¥ -94.39B¥ -77.56B
Total Liabilities¥ 51.90B¥ 62.66B¥ 57.93B¥ 56.95B¥ 55.78B
Stockholders' Equity¥ 213.47B¥ 204.82B¥ 197.90B¥ 195.60B¥ 182.58B
Cash Flow
Free Cash Flow¥ -14.81B¥ 4.79B¥ 15.69B¥ 18.23B¥ 19.84B
Operating Cash Flow¥ 11.25B¥ 18.36B¥ 31.91B¥ 22.42B¥ 23.99B
Investing Cash Flow¥ -18.41B¥ -19.58B¥ -14.31B¥ 7.99B¥ -12.66B
Financing Cash Flow¥ -7.77B¥ -19.46B¥ -20.76B¥ -10.38B¥ -6.02B
Currency in JPY

Kobayashi Pharmaceutical Co Earnings and Revenue History

Kobayashi Pharmaceutical Co Debt to Assets

Kobayashi Pharmaceutical Co Cash Flow

Kobayashi Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis